These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 9892365)
21. Routine Monitoring of Sodium and Phosphorus Removal in Peritoneal Dialysis (PD) Patients Treated with Continuous Ambulatory PD (CAPD), Automated PD (APD) or Combined CAPD+APD. Moor V; Wagner R; Sayer M; Petsch M; Rueb S; Häring HU; Heyne N; Artunc F Kidney Blood Press Res; 2017; 42(2):257-266. PubMed ID: 28531904 [TBL] [Abstract][Full Text] [Related]
22. What is the optimal frequency of cycling in automated peritoneal dialysis? Perez RA; Blake PG; McMurray S; Mupas L; Oreopoulos DG Perit Dial Int; 2000; 20(5):548-56. PubMed ID: 11117246 [TBL] [Abstract][Full Text] [Related]
23. Taking peritoneal dialysis beyond the year 2000. Gokal R Perit Dial Int; 1999; 19 Suppl 3():S35-42; discussion S43. PubMed ID: 10433550 [TBL] [Abstract][Full Text] [Related]
24. [Adequate peritoneal dialysis: limitations of continuous ambulatory peritoneal dialysis (CAPD), place of automated peritoneal dialysis (APD)]. Durand PY; Kessler M; Chanliau J Nephrologie; 1998; 19(5):239-44. PubMed ID: 9793936 [TBL] [Abstract][Full Text] [Related]
25. Peritoneal dialysis technique success during the initial 90 days of therapy. Guest S; Hayes AC; Story K; Davis ID Adv Perit Dial; 2012; 28():60-3. PubMed ID: 23311215 [TBL] [Abstract][Full Text] [Related]
26. High correlation between clearance of renal protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) and renal water-soluble toxins in peritoneal dialysis patients. Huang WH; Hung CC; Yang CW; Huang JY Ther Apher Dial; 2012 Aug; 16(4):361-7. PubMed ID: 22817125 [TBL] [Abstract][Full Text] [Related]
28. Combined peritoneal dialysis and hemodialysis therapy improves quality of life in end-stage renal disease patients. Hashimoto Y; Matsubara T Adv Perit Dial; 2000; 16():108-12. PubMed ID: 11045273 [TBL] [Abstract][Full Text] [Related]
29. Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory peritoneal dialysis in a Mexican PD center. Sanchez AR; Madonia C; Rascon-Pacheco RA Kidney Int Suppl; 2008 Apr; (108):S76-80. PubMed ID: 18379553 [TBL] [Abstract][Full Text] [Related]
30. The Use of Incremental Peritoneal Dialysis in a Large Contemporary Peritoneal Dialysis Program. Ankawi GA; Woodcock NI; Jain AK; Garg AX; Blake PG Can J Kidney Health Dis; 2016; 3():2054358116679131. PubMed ID: 28781885 [TBL] [Abstract][Full Text] [Related]
31. Peritonitis - does peritoneal dialysis modality make a difference? Piraino B; Sheth H Blood Purif; 2010; 29(2):145-9. PubMed ID: 20093820 [TBL] [Abstract][Full Text] [Related]
32. Peritoneal Phosphate Clearance: The Effect of Peritoneal Dialysis Modality and Peritoneal Transport Status. Davenport A Adv Perit Dial; 2017 Jan; 33(2017):6-12. PubMed ID: 29668423 [TBL] [Abstract][Full Text] [Related]
34. Patient and technique survival on peritoneal dialysis in the United States: evaluation in large incident cohorts. Guo A; Mujais S Kidney Int Suppl; 2003 Dec; (88):S3-12. PubMed ID: 14870873 [TBL] [Abstract][Full Text] [Related]
35. Comparing automated peritoneal dialysis with continuous ambulatory peritoneal dialysis: survival and quality of life differences? Balasubramanian G; McKitty K; Fan SL Nephrol Dial Transplant; 2011 May; 26(5):1702-8. PubMed ID: 20921296 [TBL] [Abstract][Full Text] [Related]
36. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report]. Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265 [TBL] [Abstract][Full Text] [Related]
37. The importance of an extra hour of cycler therapy to obtain better adequacy. Pagé DE; Smith CA Adv Perit Dial; 1999; 15():144-6. PubMed ID: 10682090 [TBL] [Abstract][Full Text] [Related]
38. Trends in clinical indicators of care for adult peritoneal dialysis patients in the United States from 1995 to 1997. ESRD Core Indicators Workgroup. Frankenfield DL; Prowant BF; Flanigan MJ; Frederick PR; Bailie GR; Helgerson SD; Rocco MV Kidney Int; 1999 May; 55(5):1998-2010. PubMed ID: 10231465 [TBL] [Abstract][Full Text] [Related]
39. Peritoneal membrane characteristics in patients on peritoneal dialysis. Al-wakeel J; Al-Ghonaim M; Al-Suwaida A; Askar A; Usama S; Feraz N; Shah IH; Memon N; Qudsi A; Sulaimani F Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):49-53. PubMed ID: 21196612 [TBL] [Abstract][Full Text] [Related]